You are here

Article Text

Article menu
Download PDFPDF
Editorial commentary
Libera nos a malo
  1. C Baracchini
  1. Correspondence to Professor Claudio Baracchini, Department of Neurological Sciences, University of Padua School of Medicine, Via N. Giustiniani 5, Padova 35128, Italy; claudiobaracchini{at}tin.it

https://doi.org/10.1136/jnnp-2013-305925

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Percutaneous transluminal angioplasty for treatment of chronic cerebrospinal venous insufficiency in patients with MS: a solution or a harmful illusion?

    Percutaneous transluminal angioplasty (PTA) of stenosed jugular and/or azygos veins,1 also known as the ‘liberation treatment’,2 has been proposed as a solution to improve the clinical outcome of MS patients with chronic cerebrospinal venous insufficiency (CCSVI).3

    In their paper van Zuuren and colleagues present the summary of a Cochrane systematic review outlining the randomised controlled trials (RCTs) on this topic and conclude that there is currently no evidence to support the efficacy or safety of PTA for the treatment of CCSVI in MS patients. The authors argue in favour of well-designed RCTs which may provide further, more reliable evidence to guide clinical …

    View Full Text

    Footnotes

    • Contributors I had the idea for the article, performed the literature search, wrote the article and I accept full responsibility.

    • Competing interests None.

    • Provenance and peer review Commissioned; internally peer reviewed.

    Linked Articles